Each week, many millions are invested into life sciences startups. There are so many that often, they get lost in the weeds. We’re keeping track for you – based on regulatory filings reported to the SEC:
Bergen Medical Products – Cedar Knolls, New Jersey
- $1.7 million in equity raised of a proposed $2.1 million
- In the medical device space, but not sure what they do – just “Valued Solutions You Can Trust.”
- CEO: Robert Laudadio
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
Carbylan Therapeutics – Palo Alto, California
- $5 million equity raise
- Joint pain relief
- CEO: David Renzi
Cardero Therapeutics – Sunnyvale, California
- $891,999 in equity raised of a proposed $1.5 million round
- Approaching cardiovascular and metabolic disease with a mitochondrial biogenesis approach
- CEO: George Schreiner
Gamma Medica – Salem, New Hampshire
- $6.5 million equity raise
- Breast imaging diagnostics
- CEO: Jim Calandra
- For more info: Imaging backup for the standard mammogram meant to improve breast cancer screenings
Immunome – Wynnewood, Pennyslvania
- $467,500 in debt raised of a proposed $650,000 round
- Cancer immunotherapy
- Executive Chair: Jane H. Hollingsworth
Immunomic Therapeutics – Hershey, Pennsylvania
- $6.76 million in equity raised of a proposed $8.8 million round
- CEO: William Hearl
- Vaccines for allergy, cancer and infectious disease
K-Pax Pharmaceuticals – Mill Valley, California
- $1.46 million equity raise
- Immune modulator targeting chronic fatigue
- CEO: Jon Kaiser
Integrated Healing Technologies – Franklin, Tennessee
- $4.04 million in equity raised of a proposed $7 million round
- Wound care company
- CFO: John Blount
NextGxDx – Franklin, Tennessee
- $2.23 million equity raise
- Health IT for genetic test ordering
- CEO: Mark Harris
Parsagen Diagnostics – Andover, Massachusetts
- $3.45 million equity raise
- They’re pretty vague about what they’re up to – “Medical devices focused on women’s health”
- CEO: Ruben Salinas
VolitionRx – Singapore and Belgium
- $1.1 million equity, in two filings – $750,000 and $229,393
- Colorectal cancer diagnostics
- CEO: Cameron Reynolds
- For more info: Colorectal cancer screening could be whittled down to a drop of blood